Medscape UK | Univadis prescription drug monographs & interactions are
based on FDB Multilex Content

FDB Disclaimer:
IMPORTANT NOTICE:
First Databank UK Ltd is proud of the extensive editorial and quality control
procedures which it has developed over many years. However, since every
patient's history is different, and even the most exhaustive sources of
information cannot cover every possible eventuality, you should be aware
that all information is provided from FDB Multilex on the basis that the
healthcare professionals responsible for patient care will retain FULL and SOLE
responsibility for deciding what treatment to prescribe or dispense for
all patients and, in particular whether the use of any drug or other
products is safe, appropriate or effective for any particular patient or
in any particular circumstances. This is because (and all healthcare
professionals should bear in mind):
- FDB Multilex are intended to supplement, not substitute for, the expertise
and judgment of physicians, pharmacists or other healthcare professionals
and should not be taken as an indication of suitability of a particular
treatment for a particular individual.
- FDB Multilex and those who are responsible for their construction, operation
and maintenance do not know the particular circumstances, condition or
medical history of particular patients or groups of patients and so
cannot advise as to particular cases.
- While FDB Multilex use reputable sources of information, such as published
data of pharmaceutical manufacturers, it does not validate or verify the
information received from third parties.
- The information stored on FDB Multilex is not exhaustive. It therefore
cannot be relied upon as complete.
- Although the information stored on FDB Multilex is updated on a regular
basis, healthcare professionals should ensure that they are satisfied
that the information they have is current.
FDB Disclaimer
: FDB Multilex is intended for the use of healthcare
professionals and is provided on the basis that the healthcare
professionals will retain FULL and SOLE responsibility for deciding
what treatment to prescribe or dispense for any particular patient or
circumstance.